Cresco Labs schedules November 6 results for Cresco Labs stock

Published on 10/27/2026 at 22:39 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Q2 revenue reached USD 173.34 million and net income USD 16.80 million. Cresco Labs stock costs EUR 0.56 on October 27, 2026 at 10:35 p.m. CET.

Reporting dates and Q2 figures

Cresco Labs scheduled third-quarter results for November 6, 2026.
Second-quarter revenue reached USD 173.34 million and net income reached USD 16.80 million.
Cresco Labs stock costs EUR 0.56 at Lang & Schwarz on October 27, 2026 at 10:35 p.m. CET.
The company reported 2,900 employees and a CAD 308.1 million market capitalization as of October 27, 2026.

CL, CA22587M1068, Illustration mit AI erstellt.

Cresco Labs (CA22587M1068) will report third-quarter results on November 6, 2026, after the company announced the date on October 15, 2026. The stock was trading at EUR 0.56 at Lang & Schwarz on October 27, 2026 at 10:35 p.m. CET.

Second-quarter profit sets the benchmark

In the second quarter ended June 30, 2026, Cresco Labs generated USD 173.34 million in revenue and USD 16.80 million in net income. The figures marked a change from the year-earlier quarter, when revenue was USD 163.62 million and net income was a USD 16.33 million loss, according to Yahoo Finance.

The second-quarter operating result was USD 13.36 million, while operating cash flow reached USD 15.43 million. Free cash flow was USD 4.45 million in the same period, giving the November report a clear profitability and cash-generation benchmark.

Price remains near the yearly low

On the Canadian Securities Exchange, Cresco Labs was last quoted at CAD 0.87 on October 27, 2026 at 3:58 p.m. ET. The same quotation showed a 52-week range of CAD 0.81 to CAD 3.12 and a market capitalization of CAD 308.1 million. The current Canadian quote is 7.41 percent above the yearly low, calculated from CAD 0.87 and CAD 0.81.

The company operates branded cannabis products and Sunnyside dispensaries across the United States. Its investor-relations profile says Cresco Labs has a presence in eight states, while the company profile lists 2,900 employees.

Two dates shape the next update

Shareholders are scheduled to vote on corporate and listing-related measures at the annual general and special meeting on October 30, 2026, according to The Globe and Mail. The next quarterly report follows on November 6, 2026, before the US market opens, with a conference call scheduled for 8:30 a.m. ET, according to Cresco Labs.

What the November report must clarify

The central comparison will be whether quarterly revenue can stay above the USD 173.34 million second-quarter level while net income remains positive. The balance sheet carried USD 592.02 million of total debt and USD 32.87 million in cash as of June 30, 2026, making operating cash flow another important figure for the next release.

Stock price and investor calendar

The November 6 report will give investors a fresh test of Cresco Labs' recent return to quarterly profitability and its ability to fund operations. The stock was trading at EUR 0.56 at Lang & Schwarz on October 27, 2026 at 10:35 p.m. CET.

The further course of trading is shown by the continuously updated real-time quote of Cresco Labs stock.